skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Download the article pack below

Go inside the restructuring strategies being rolled out by Big Pharma as they look towards to a new year and a new decade.

Articles include:

  • “Countdown To The Allergan Merger, And More From AbbVie’s Q4 Earnings”
  • “Pharma Is Priority As GSK Confirms Split With Consumer”
  • “BMS Earnings Beat Estimates, But Opdivo Sales Slide Continues”
  • “Gilead Writes Down Kite Buy As Yescarta Sales Flatten Out”
  • “Stockwatch: Gilead, BMS Expose High Cost Of M&A”
  • And many more 

Read also


Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free   : +1 888 670 8900  
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (20) 805 20700
  • Australia        : +61 2 8705 6907

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: